TELEFLEX MEDICAL INC recalls Arrow-Trerotola Over-The-Wire PTD Kit, Percutaneous Thrombolytic Device, REF PT-65709-WC containing components: PT-6570…
- Recall date
- January 11, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0626-2022
- FDA classification
- Class I
- Brand / firm
- TELEFLEX MEDICAL INC
- Sold / distributed
- Worldwide distribution: US Nationwide and the countries of AU, BE, CA, CL, CZ, DE, ES, FR, GB, IL, IT, KR, KW, NL, PA, PH, PT, SA, TR.
Why it was recalled
The firm received reports indicating PTD tip separation during use.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Arrow-Trerotola Over-The-Wire PTD Kit, Percutaneous Thrombolytic Device, REF PT-65709-WC containing components: PT-65709-C, PT-03009, PT-65709-HS The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit, permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.
Get recall alerts
Free email alert whenever TELEFLEX MEDICAL INC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: TELEFLEX MEDICAL INC